Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening
Drug Development Research · 2026-05 · 87 (3)
DOI: 10.1002/ddr.70290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 27.04.2026. Verfasst von Xin Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Protein Kinase Inhibitors, Pyrroles. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
RIPK1 regulates the pathways in programmed cell death, and is closely associated with inflammatory and immune diseases. Based on the pharmacophore‐based virtual screening, compound 15 , a tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione derivative, was identified as a hit of RIPK1 inhibitor with an IC 50 value of 6.42 μM. Furthermore, a similarity searching was carried out to get more potent RIPK1 inhibitors. Among them, compound 21 showed obvious improvement in RIPK1 inhibitory activity with an IC 50 value of 2.21 μM, accompanied with moderate anti‐necroptosis activity in HT‐29 cells (IC 50 = 15.32 μM). Molecular dynamics (MD) simulations indicated that it probably functioned as a type III kinase inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- Jinhua Institute of Zhejiang University, Zhejiang Provincial Engineering Research Center for Innovative Small-Molecule Drugs, Jinhua, China.
ORCID-Profile: Xin Zeng, Rong Sheng
Zitieren
APA
Zeng, X., Yu, Y., Wu, Y., Chen, G., & Sheng, R. (2026). Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening. Drug Development Research, 87(3). https://doi.org/10.1002/ddr.70290
Vancouver
Zeng X, Yu Y, Wu Y, Chen G, Sheng R. Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening. Drug Development Research. 2026;87(3). doi:10.1002/ddr.70290
BibTeX
@article{Zeng2026,
author = {Zeng, Xin and Yu, Yanzhen and Wu, Yifan and Chen, Geng and Sheng, Rong},
title = {Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {3},
doi = {10.1002/ddr.70290}
}
EUVIMED